Laboratory Based Analyses of Human Sera and Cerebrospinal Fluid from Autoimmune Diseases With and Without Autoantibodies

Overview

About this study

This study aims to identify serological and other blood biomarkers to aid in identificaiton of diagnosis and mechanistic understanding of autoimmune disorders.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

All ages.

Exclusion Criteria:

N/A.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/21/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Divyanshu Dubey, M.B.B.S.	Open for enrollment	Contact information: Morgan Mohler (507) 293-9803 Mohler.Morgan@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Divyanshu Dubey, M.B.B.S.

Open for enrollment

Contact information:

Morgan Mohler

(507) 293-9803

Mohler.Morgan@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials